. Author manuscript; available in PMC: 2012 Nov 1.

Published in final edited form as: Am J Med Sci. 2011 Nov;342(5):356–364. doi: 10.1097/MAJ.0b013e3182113658

Table 1.

Data on confirmed (and complicated) PUBS in the Alzheimers’ Trial Protocol #078.

	Placebo		Rofecoxib
Patients with confirmed complicated PUBS	3		10
Patient-years at risk	1579		1375
Rate (per 100 patient-years at risk)	0.19		0.73
Incidence Rate Ratio (with the rate under rofecoxib in the numerator) 95% CI (exact)		3.83 (0.99, 21.65)
Patients with confirmed PUBS	4		14
Patient-years at risk	1579		1375
Rate (per 100 patient-years at risk)	0.25		1.02
Incidence Rate Ratio (with the rate under rofecoxib in the numerator) 95% CI		4.02 (1.26, 16.77)